Tofacitinib Ameliorates Lupus Through Suppression of T Cell Activation Mediated by TGF-Beta Type I Receptor.

Front Immunol · 2021 · PMC8358742 · PMID 34394075

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

However, TGFβRII mRNA expression showed an increasing trend after tofacitinib intervention but did not reach statistical difference ( Supplementary Figure 3A ).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.